Enhancing antidiabetic and antimicrobial performance of Ocimum basilicum, and Ocimum sanctum (L.) using silver nanoparticles

Saudi Journal of Biological Sciences

Volumn 24, Issue 6, 2017, Pages 1294-1305

  Malapermal, Veshara ^a   Botha, Izel ^a   Krishna, Suresh Babu Naidu ^a   Mbatha, Joyce Nonhlanhla ^a  

^a DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

AgNps; Diabetes mellitus; Ocimum basilicum; Ocimum sanctum; Silver nanoparticles; Glucosidase

Indexed keywords

EID: 84936791941     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2015.06.026     Document Type: Article

References (68)

1. Ahmad, I., Beg, A.Z., Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J. Ethnopharmacol. 74 (2001), 113–123.
2. Ahmad, N., Sharmab, S., Alama, M.K., Singh, V.N., Shamsid, S.F., Mehtac, B.R., Fatmae, A., Rapid synthesis of silver nanoparticles using dried medicinal plant of basil. Colloids Surf. B 81 (2010), 81–86.
3. Ali, H., Houghton, P.J., Soumyanath, A., α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes with particular reference to Phyllanthus amarus. J. Ethnopharmacol. 107 (2006), 449–455.
4. Alkaladi, A., Abdelazim, A.M., Afifi, M., Antidiabetic activity of zinc oxide and silver nanoparticles on streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 15 (2014), 2015–2023.
5. Aujla, M.I., Ahmed, D., Khair-Ul-Bariyah, S., Comparative analysis of Ocimum basilicum and Ocimum sanctum: extraction techniques and urease and alpha-amylase inhibition. Pak. J. Chem. 2 (2012), 134–141.
6. Avery, M.A., Mizuno, C.S., Chittiboyina, A.G., Kurtz, T.W., Pershadsingh, H.A., Type 2 diabetes and oral antihyperglycemic drugs. Curr. Med. Chem. 15 (2008), 61–74.
7. Bariyah, S.K., An extensive survey of the phytochemistry and therapeutic potency of Ocimum sanctum (Queen of Herbs). Pak. J. Chem. 3 (2013), 8–18.
8. Bernfeld, P., 1955. Methods in Enzymology 1. Available: < http://www.sigmaaldrich.com/technical- documents/ protocols/ biology/enzymatic-assay-of-a-amylase.html> (accessed 04/11/2012).
9. Bouwmeester, H., Dekkers, S., Noordam, M.Y., Hagens, W.I., Bulder, A.S., De Heer, C., Ten Voorde, S.E., Wijnhoven, S.W., Marvin, H.J., Sips, A.J., Review of health safety aspects of nanotechnologies in food production. Regul. Toxicol. Pharmacol. 53 (2009), 52–62.
10. Chattopadhyay, R.R., Hypoglycemic effect of Ocimum sanctum leaf extract in normal and streptozotocin diabetic rats. Indian J. Exp. Biol. 31 (1993), 891–893.
11. Cheng, Y., Prusoff, W.H., Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973), 3099–3108.
12. Cryer, P.E., Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr. Pract. 14 (2008), 750–756.
13. Ehdaie, B., Application of nanotechnology in cancer research: review of progress in the National Cancer Institute's Alliance for Nanotechnology. Int. J. Biol. Sci., 3, 2007, 108.
14. El-Beshbishy, H., Bahashwan, S., Hypoglycemic effect of basil (Ocimum basilicum) aqueous extract is mediated through inhibition of α-glucosidase and α-amylase activities: an in vitro study. Toxicol. Ind. Health 28 (2012), 42–50.
15. Eloff, J.N., Which extractant should be used for the screening and isolation of antimicrobial components from plants?. J. Ethnopharmacol. 60 (1998), 1–8.
16. Gavanji, S., Mohabatkar, H., Baghshahi, H., Zarrabi, A., Bioinformatics prediction of interaction silver nanoparticles on the disulfide bonds of HIV-1 Gp120 protein. Int. J. Sci. Res. Knowl. 2 (2014), 67–74.
17. Gengan, R.M., Anand, K., Phulukdaree, A., Chuturgoon, A., A549 lung cell line activity of biosynthesized silver nanoparticles using Albizia adianthifolia leaf. Colloids Surf. B 105 (2013), 87–91.
18. German Homoeopathic Pharmacopoeia, German homoeopathic pharmacopoeia: GHP. 2005, Medpharm Scientific Publ, Stuttgart.
19. Govind, P., Madhuri, S., Pharmacological Activities of Ocimum sanctum (Tulsi): a Review. Int. J. Pharm. Sci. Rev. Res. 5 (2010), 61–66.
20. Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103 (2014), 137–149.
21. Guo, D., Zhu, L., Huang, Z., Zhou, H., Ge, Y., Ma, W., Wu, J., Zhang, X., Zhou, X., Zhang, Y., Zhao, Y., Gu, N., Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 34 (2013), 7884–7894.
22. Hall, V., Thomsen, R.W., Henriksen, O., Lohse, N., Diabetes in Sub Saharan Africa 1999–2011: epidemiology and public health implications. A systematic review. B.M.C. Public Health, 11, 2011, 564.
23. Hannan, J.M., Marenah, L., Ali, L., Rokeya, B., Flatt, P.R., Abdel-Wahab, Y.H., Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic beta-cells. J. Endocrinol. 189 (2006), 127–136.
24. Hannan, J.M.A., Ojo, O.O., Ali, L., Rokeya, B., Khaleque, J., Akhter, M., Flatt, P.R., Abdel-Wahab, Y.H.A., Actions underlying antidiabetic effects of Ocimum sanctum leaf extracts in animal models of type 1 and type 2 diabetes. Eur. J. Med. Plants 5 (2015), 1–12.
25. Huang, J., Li, Q., Sun, D., Lu, Y., Su, Y., Yang, X., Wang, H., Wang, Y., Shao, W., Ning, H., Hing, J., Chen, C., Biosynthesis of silver and gold nanoparticles by novel sundried Cinna-mommum camphora leaf. Nanotechnology, 18, 2007, 104.
26. Jaiganesh, K.P., Baskar, N., Ramasamy, N., Arunachalam, G., Phytochemical and antimicrobial screening of Ocimum basilicum. Linn. J. Sci. Res. Pharm. 1 (2012), 102–106.
27. Joshi, B., Sah, G.P., Basnet, B.B., Bhatt, M.R., Sharma, D., Subedi, K., Pandey, J., Malla, R., Phytochemical extraction and antimicrobial properties of different medicinal plants: Ocimum sanctum (Tulsi), Eugenia caryophyllata (Clove), Achyranthes bidentata (Datiwan) and Azadirachta indica (Neem). J. Microbiol. Antimicrob. 3 (2011), 1–7.
28. Karthick, V., Kumar, V.G., Dhas, T.S., Singaravelu, G., Sadiq, A.M., Govindaraju, K., Effect of biologically synthesized gold nanoparticles on alloxan-induced diabetic rats-an in vivo approach. Colloids Surf. B 122 (2014), 505–511.
29. Kaya, I., Yiğit, N., Benli, M., Antimicrobial activity of various extracts of Ocimum basilicum L. and observation of the inhibition effect on bacterial cells by use of scanning electron microscopy. Afr. J. Tradit. Complement. Altern. Med. 5 (2009), 363–369.
30. Khogare, D.T., Lokhande, S.M., Effect of Tulasi (Ocimum sanctum) on diabetes mellitus. Indian Sreams Res. J. 1 (2011), 189–191.
31. Kim, M.J., Lee, S.B., Lee, H.S., Lee, S.Y., Baek, J.S., Kim, D., Moon, T.W., Robyt, J.F., Park, K.H., Comparative study of the inhibition of α-glucosidase, α-amylase, and cyclomaltodextrin glucanosyltransferase by acarbose, isoacarbose, and acarviosine-glucose. Arch. Biochem. Biophys. 371 (1999), 277–283.
32. Kotakadi, V.S., Gaddam, S.A., Rao, Y.S., Prasad, T.N.V.K.V., Reddy, A.V., Sai Gopal, D.V.R., Biofabrication of silver nanoparticles using Andrographis paniculata. Eur. J. Med. Chem. 73 (2014), 135–140.
33. Kothari, S.K., Bhattacharya, A.K., Ramesh, S., Essential oil yield and quality of methyl eugenol rich Ocimum tenuiflorum L.f. (Syn. O. sanctum L.) grown in south India as influenced by method of harvest. J. Chromatogr. A 1054 (2004), 67–72.
34. Krishnamoorthy, P., Jayalakshmi, T., Preparation, characterization and synthesis of silver nanoparticles by using phyllanthusniruri for the antimicrobial activity and cytotoxic effects. J. Chem. Pharm. Res. 4 (2012), 4783–4794.
35. Kumari, M.M., Jacob, J., Philip, D., Green synthesis and applications of Au–Ag bimetallic nanoparticles. Spectrochim. Acta Mol. Biomol. Spectrosc. 137 (2015), 185–192.
36. Lee, S.J., Umano, K., Shibamoto, T., Lee, K.G., Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem. 91 (2005), 131–137.
37. Lokina, S., Stephen, A., Kaviyarasan, V., Arulvasu, C., Narayanan, V., Cytotoxicity and antimicrobial activities of green synthesized silver nanoparticles. Eur. J. Med. Chem. 76 (2014), 256–263.
38. Losasso, C., Belluco, S., Cibin, V., Zavagnin, P., Mičetić, I., Gallocchio, F., Zanella, M., Bregoli, L., Biancotto, G., Ricci, I., Antibacterial activity of silver nanoparticles: sensitivity of different Salmonella serovars. Front Microbiol. 5 (2014), 1–9.
39. Mccue, P.P., Shetty, K., Inhibitory effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac. J. Clin. Nutr. 13 (2004), 101–106.
40. Mo, R., Jiang, T., Di, J., Tai, W., Gu, Z., Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. Chem. Soc. Rev. 43 (2014), 3595–3629.
41. Mogale, M.A., Lebelo, S.L., Thovhogi, N., De Freitas, A.N., Shai, L.J., Alpha-Amylase and alpha-glucosidase inhibitory effects of Sclerocarya birrea [(A. Rich.) Hochst.] subspecies caffra (Sond) Kokwaro (Anacardiaceae) stem-bark extracts. Afr. J. Biotech. 10 (2011), 15033–15039.
42. Morones, J.R., Elechiguerra, J.L., Camacho, A., Holt, K., Kouri, J.B., Yacaman, M.J., The bactericidal effect of silver nanoparticles. Nanotechnology 16 (2005), 2346–2353.
43. Mubarak, A.D., Thajuddin, N., Jeganathan, K., Gunasekaran, M., Plant extract mediated synthesis of silver and gold nanoparticles and its antibacterial activity against clinically isolated pathogens. Colloids Surf. B 85 (2011), 360–365.
44. Mukherjee, P., Maiti, K., Mukherjee, K., Houghton, P., Leads from Indian medicinal plants with hypoglycemic potentials. J. Ethnopharmacol. 106 (2006), 1–28.
45. Nguyen, T.H., Um, B.H., Kim, S.M., Two unsaturated fatty acids with potent α-glucosidase inhibitory activity purified from the body wall of sea cucumber (Stichopus japonicus). J. Food Sci. 76 (2011), 208–214.
46. Panneerselvam, C., Murugan, K., Amerasan, D., Biosynthesis of silver nanoparticles using plant extract and its anti-plasmodial property. Adv. Mater. Res. 1086 (2015), 11–30 Trans. Tech. Publ.
47. Patel, D., Kumar, R., Laloo, D., Hemalatha, S., Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac. J. Trop. Biomed. 2 (2012), 411–420.
48. Prabhu, D., Arulvasu, C., Babu, G., Manikandan, R., Srinivasan, P., Biologically synthesized green silver nanoparticles from leaf extract of Vitex negundo L. induce growth-inhibitory effect on human colon cancer cell line HCT15. Process Biochem. 48 (2013), 317–324.
49. Raman, S., Kandula, M.P., Jacob, J.A., Soundararajan, K., Ramar, T., Palani, G., Muthukalingan, K., Shanmugam, A., Cytotoxic effect of Green synthesized silver nanoparticles using Melia azedarach against in vitro HeLa cell lines and lymphoma mice model. Process Biochem. 47 (2012), 273–279.
50. Ramteke, C., Chakrabarti, T., Sarangi, B.K., Pandey, R.A., Synthesis of silver nanoparticles from the aqueous extract of leaves of Ocimum sanctum for enhanced antibacterial activity. J. Chem. 2013 (2013), 1–7.
51. Rao, Y.S., Kotakadi, V.S., Prasad, T.N.V.K.V., Reddy, A.V., Gopal, D.V.R.S., Green synthesis and spectral characterization of silver nanoparticles from Lakshmi tulasi (Ocimum sanctum) leaf extract. Spectrochim. Acta Mol. Biomol. Spectrosc. 103 (2013), 156–159.
52. Ratner, R.E., Glycemic control in the prevention of diabetic complications. Clin. Cornerstone 4 (2001), 24–37.
53. Reid, M.J.A., Tsima, B.M., Kirk, B., HIV and diabetes in Africa. Afr. J. Diabetes Med. 20 (2012), 28–32.
54. Rout, Y., Behera, S., Ojha, A.K., Nayak, P.L., Green synthesis of silver nanoparticles using Ocimum sanctum (Tulashi) and study of their antibacterial and antifungal activities. J. Microbiol. Antimicrob. 4 (2012), 103–109.
55. Saha, S., Dhar, T.N., Sengupta, C., Ghosh, P., Biological activities of essential oils and methanol extracts of five Ocimum species against pathogenic bacteria. Czech J. Food Sci. 31 (2013), 194–202.
56. Sahoo, S.K., Parveen, S., Panda, J.J., The present and future of nanotechnology in human health care. Nanomedicine 3 (2007), 20–31.
57. Shankar, E.M., Mohan, V., Premalatha, G., Srinivasan, R.S., Usha, A.R., Bacterial etiology of diabetic foot infections in South India. Eur. J. Intern. Med. 16 (2005), 567–570.
58. Singhal, G., Bhavesh, R., Kasariya, K., Sharma, A.R., Singh, R.P., Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J. Nanopart. Res. 13 (2011), 2981–2988.
59. Sivaranjani, K., Meenakshisundaram, M., Biological synthesis of silver nanoparticles using Ocimum basilicum leaf extract and their antimicrobial activity. Int. Res. J. Pharm. 4 (2013), 225–229.
60. Sondi, I., Salopek-Sondi, B., Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275 (2004), 177–182.
61. Song, J.Y., Kim, B.S., Rapid biological synthesis of silver nanoparticles using plant leaf extracts. Bioprocess Biosyst. Eng. 32 (2009), 79–84.
62. Subramanian, R., Asmawi, M.Z., Sadikun, A., In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim. Pol. 55 (2008), 391–398.
63. Sudha, P., Zinjarde, S., Bhargava, S., Kumar, A., Potent alpha-amylase inhibitory activity of Indian Ayurvedic medicinal plants. B.M.C. Complement Altern Med., 11(5), 2011.
64. Swarnalatha, L., Rachela, C., Ranjanb, S., Baradwaj, P., Evaluation of in vitro antidiabetic activity of Sphaeranthus Amaranthoides silver nanoparticles. J. Nanomater. Biol. 2 (2012), 25–29.
65. Tudhope, L., The diabetic foot: protocols and current therapies. Wound Healing South Afr. 1 (2008), 37–39.
66. Usman, L.A., Ismaeel, R.O., Zubair, M.F., Saliu, B.K., Olawore, N.O., Elelu, N., Comparative studies of constituents and antibacterial activities of leaf and fruit essential oils of Ocimium basilicum grown in north central Nigeria. Int. J. Chem. Biol. Sci. 3 (2013), 47–52.
67. Venkatachalam, M., Govindaraju, K., Sadiq Mohamed, A., Tamilselvan, S., Ganesh Kumar, V., Singaravelu, G., Functionalization of gold nanoparticles as antidiabetic nanomaterial. Spectrochim. Acta A Mol. Biomol. Spectrosc. 116 (2013), 331–338.
68. Woldu, M.A., Lenjisa, J.L., Nanoparticles and the new era in diabetes management. Int J. Basic Clin. Pharmacol. 3 (2014), 277–284.